Form 8-K Skye Bioscience, Inc. For: Oct 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Axsome Therapeutics (AXSM) PT Raised to $380 at Jefferies
Craig-Hallum Downgrades Skye Bioscience (SKYE) to Hold
October 6, 2025 12:11 PM EDTCraig-Hallum analyst Albert Lowe downgraded Skye Bioscience (NASDAQ: SKYE) from Buy to Hold with a price target of $2.00.
For an analyst ratings summary and ratings history on Skye Bioscience click here. For more ratings news on Skye Bioscience click here.
Shares of Skye Bioscience closed at $4.75 yesterday.
... More